Inflammaging Module

This is the most direct intervention evidence attached to this module and also the easiest to over-read. The manipulation is transgenic overexpression of a foreign synthase, producing tissue hyaluronan levels that no dietary or pharmacological route reproduces, so the effect size is not a guide to what a human intervention would achieve. The authors themselves attribute the benefit to high-molecular-mass hyaluronan rather than to the naked mole-rat gene, which is the useful part of the finding - the effector is a polymer, not a species' allele - but it also means the result does not license reading nmrHas2 as a druggable target. Two further gaps sit between this model and human aging. Hyaluronan is already in wide clinical use as viscosupplementation and as a dermal filler, at routes and doses that do not produce sustained systemic high-molecular-mass tissue hyaluronan, so existing human exposure is not evidence about this mechanism either way. And part of the survival benefit in these mice ran through cancer resistance, which in the source species is a direct effect of the polymer on transformation rather than a consequence of reduced inflammation, so the lifespan result cannot be attributed to this module's chain without isolating the inflammatory arm.

A diverse set of age-accumulating stimuli feed sterile inflammation: senescent-cell SASP, damage-associated molecular patterns from dysfunctional mitochondria, NLRP3 inflammasome activation, increased gut permeability and microbiota changes, central obesity, immune-cell dysregulation, and chronic infections. Regardless of the dominant source, these converge to drive a persistent inflammatory response.

The persistent stimuli establish a chronic, low-grade, sterile inflammatory state - elevated circulating inflammatory mediators without overt infection. This is the defining central effector of inflammaging and the conserved node that disease-specific inflammatory drivers converge upon.

The inflammatory state is propagated beyond its cells of origin through altered intercellular communication - circulating cytokines, chemokines, and other mediators acting at a distance. This systemic cytokine signaling is the amplifying step that converts local inflammatory sources into a body-wide aging phenotype, and is itself one of the enumerated hallmarks of aging.

Sustained systemic inflammation is a shared pathogenic substrate for the major age-related diseases - cardiovascular disease, chronic kidney disease, diabetes, cancer, dementia, sarcopenia, and frailty - and a significant risk factor for morbidity and mortality in older people. This is the conserved consequence of inflammaging; the specific disease phenotype is supplied by the conforming disorder.